Now showing items 1-3 of 3

    • Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis. 

      Yi, JS; Guidon, A; Sparks, S; Osborne, R; Juel, VC; Massey, JM; Sanders, DB; ... (9 authors) (J Autoimmun, 2014-08)
      Muscle specific tyrosine kinase myasthenia gravis (MuSK MG) is a form of autoimmune MG that predominantly affects women and has unique clinical features, including prominent bulbar weakness, muscle atrophy, and excellent ...
    • Myasthenia gravis. 

      Juel, Vern C; Massey, Janice M (Orphanet J Rare Dis, 2007-11-06)
      Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups. Ocular ...
    • Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment. 

      Yi, John S; Decroos, Emily C; Sanders, Donald B; Weinhold, Kent J; Guptill, Jeffrey T (Muscle Nerve, 2013-12)